Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Randomized controlled trials with a survival endpoint are the gold standard for clinical research, but have failed to achieve cures for most advanced malignancies. The high costs of randomized clinical trials slow progress (thereby causing avoidable loss of life) and increase health care costs. |